Actavis recalls flurandrenolide tape; Recipharm lines up deal; India explores boosting API production;

> Actavis is recalling 78,522 cartons of flurandrenolide tape used to treat inflammation and itching due to certain skin conditions because it may not meet potency specifications. Notice

> Sweden's Recipharm has a letter of intent with LIDDS that it would handle the scale-up, manufacture and quality assurance of LIDDS' pharmaceutical products. Report

> Apotex is recalling 33,795 bottles of bromfenac ophthalmic solution because the excipient was not retested at the appropriate date. Notice

> The Indian government is considering recommendations on how to support API manufacturing in the country. Report

Suggested Articles

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

Boehringer Ingelheim is investing $50 million in an animal health plant in Puerto Rico, adding 105 jobs.

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.